175 related articles for article (PubMed ID: 32115255)
1. The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study.
Turk T; Saad AM; Al-Husseini MJ; Gad MM
Curr Probl Cancer; 2020 Apr; 44(2):100511. PubMed ID: 32115255
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
3. Second cancers in patients with chronic lymphocytic leukemia.
Travis LB; Curtis RE; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
5. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
7. Management of melanoma in patients with chronic lymphocytic leukemia.
Archibald WJ; Meacham PJ; Williams AM; Baran AM; Victor AI; Barr PM; Sahasrahbudhe DM; Zent CS
Leuk Res; 2018 Aug; 71():43-46. PubMed ID: 30005183
[TBL] [Abstract][Full Text] [Related]
8. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
9. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
10. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
13. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
[TBL] [Abstract][Full Text] [Related]
14. Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia.
Kleinstern G; Rishi A; Achenbach SJ; Rabe KG; Kay NE; Shanafelt TD; Ding W; Leis JF; Norman AD; Call TG; Cerhan JR; Parikh SA; Baum CL; Slager SL
J Am Acad Dermatol; 2020 Dec; 83(6):1581-1589. PubMed ID: 32682027
[TBL] [Abstract][Full Text] [Related]
15. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
[TBL] [Abstract][Full Text] [Related]
16. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
17. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
18. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
[TBL] [Abstract][Full Text] [Related]
19. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma.
Brewer JD; Christenson LJ; Weenig RH; Weaver AL
Dermatol Surg; 2010 Mar; 36(3):368-76. PubMed ID: 20100262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
